FUM — Futura Medical Share News
0.000.00%
Last trade - 00:00- £3.84m
- £2.60m
- £1.70m
MED3000 (Eroxon®) European Patent Opposition
Holding(s) in Company
Highly positive data from WSD4000 studies
New US commercial partner
Notice of AGM & availability of Annual Report
Holding(s) in Company
Brief: Futura Actively Considering Some Dilutive And Non-Dilutive Funding And Strategic Initiatives
Unaudited Results for the Year Ended 31 Dec 2025
Notice of Results & Investor Presentation
Formal Grant of US Patent
Holding(s) in Company
Holding(s) in Company
Brief: Futura Medical Gets Notice Of Allowance Of Its US Continuation Patent
Expects Fy25 Revenue Of £1.7 Million, Exceeding Expectations
Trading Update
Holding(s) in Company
Holding(s) in Company
Brief: Futura Medical Reports Positive Results From WSD4000 Early Feasibility Study
Results of WSD4000 Early Feasibility Study